Silver Book Fact

Growth hormone treatment in patients with fibromyalgia is effective in reducing pain with sustained action over time.

Cuatrecasas, Guileem, C Alegre, J Fernandez-Sola, MJ Gonzalez, F Garcia-Fructuoso, V Poca-Dias, A Nadal, Gabriel Cuatrecasas, F Navarro, A Mera, M Lage, R Peino, F Casanueva, C Linan, G Sesmilo, MJ Coves, JP Izquierdo, I Alvarez, E Granadas, adn M Puig-Domingo. Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia. Pain. 2012; 153(7): 1382-9. http://www.ncbi.nlm.nih.gov/pubmed/22465047

Reference

Title
Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia
Publication
Pain
Publication Date
2012
Authors
Cuatrecasas, Guileem, C Alegre, J Fernandez-Sola, MJ Gonzalez, F Garcia-Fructuoso, V Poca-Dias, A Nadal, Gabriel Cuatrecasas, F Navarro, A Mera, M Lage, R Peino, F Casanueva, C Linan, G Sesmilo, MJ Coves, JP Izquierdo, I Alvarez, E Granadas, adn M Puig-Domingo
Volume & Issue
Volume 153, Issue 7
Pages
1382-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.  
  • Opioids have been found to reduce pain intensity and improve physical functioning for patients with persistent noncancer pain. It’s important to note that a decrease in mental health functioning…  
  • Topical capsaicin was found in a meta-analysis to provide a degree of pain relief to some patients with painful neuropathic conditions.  
  • Statin use in mouse models show pain-alleviating effects for neuropathic pain.  
  • A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.